Connect Biopharma Holdings Limited (CNTB)
Nasdaq: CNTB · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Mar 31, 2026 | Mar 31, 2025 | Apr 16, 2024 | Apr 11, 2023 |
| Revenue | 64 | 26,033 | 0 | · |
| Research and development | 37,798 | 29,256 | 53,002 | · |
| General and administrative | 20,340 | 19,229 | 16,054 | · |
| Total operating expenses | 58,138 | 48,485 | 69,056 | · |
| Operating income | -58,074 | -22,452 | -69,056 | · |
| Interest and investment income | 2,268 | 4,453 | 5,223 | · |
| Other income (expense), net | 523 | 2,594 | 1,847 | · |
| Total non-operating income (expense) | 2,791 | 7,047 | 7,070 | · |
| Income before income taxes | -55,283 | -15,405 | -61,986 | · |
| Income tax expense | 197 | 223 | 120 | · |
| Net income | -55,480 | -15,628 | -62,106 | · |
| Earnings per share, basic | -1.00 | -0.28 | -1.13 | · |
| Earnings per share, diluted | -1.00 | -0.28 | -1.13 | · |
| Weighted average shares, basic | 55,660 | 55,213 | 55,067 | · |
| Weighted average shares, diluted | 55,660 | 55,213 | 55,067 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeNonoperatingOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding